NASDAQ
GEHC
Last Price
US $64.01
KEY FIGURES
MKT CAP
$29.9B
EPS
TTM
$3.30
PEG
TTM
-
P/E
TTM
19.93x
P/S
TTM
1.45x
YIELD
0.21%
GROWTH
Revenue Y/Y
Profit margin
Current Ratio
Capital Returns
14.77%
Return on equity
ROIC: 6.71%
Valuation History
19.9X
Price to Earnings
EV/EBITDA: 11.3X
Cash flow
Profit margin
3.74%
(FY vs FY)
EBITDA Y/Y
2.13%
(FY vs FY)
Cash flow Y/Y
1.07%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $64.01
-55.60%
Default assumptions
EBITDA Multiple
Fair Value
Market $64.01
-28.07%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
GE HealthCare Technologies Inc. cash flow to debt ratio of 19.87% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial risk - Healthy cash flow growth.
GE HealthCare Technologies Inc.'s free cash flow has decreased -2.84% from $1.55G last year to $1.51G, signaling decreasing performance
Financial risk - Healthy debt to equity ratio.
GE HealthCare Technologies Inc.'s debt to equity ratio is 0.99, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial stability - Healthy debt to equity ratio development.
GE HealthCare Technologies Inc.'s debt has decreased relative to shareholder equity from 1.11 last year to 0.99 today, signaling strengthened financials
Financial stability - Net debt/EBITDA.
GE HealthCare Technologies Inc. has a net debt to EBITDA ratio of 1.45x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
GE HealthCare Technologies Inc.'s interest coverage ratio of 5.71 indicates that earnings with good margin can cover interest payments on company debt
Financial risk - Profit margin growth.
GE HealthCare Technologies Inc.'s profit margin has decreased (-25.55%) in the last year from 10.13% to 7.54%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
GE HealthCare Technologies Inc.'s short-term assets of $10.70G exceed its short-term liabilities of $9.11G
Decreasing performance - ROA.
GE HealthCare Technologies Inc.'s return on assets of 4.05% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
GE HealthCare Technologies Inc.'s return on equity of 14.77%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
GE HealthCare Technologies Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Increasing performance - Earnings stability.
GE HealthCare Technologies Inc. had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
GE HealthCare Technologies Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
GE HealthCare Technologies Inc. has a free cash flow yield of 5.03%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
GE HealthCare Technologies Inc.'s yearly earnings has increased 4.57% since last year from $1.99G to $2.08G, signaling increasing performance
Decreasing performance - Healthy revenue growth.
GE HealthCare Technologies Inc.'s yearly revenue has decreased -0.37% since last year from $19.67G to $19.60G, signaling decreasing performance
Increasing performance - ROIC.
ROIC 6.71% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.
Increasing performance - 3-year revenue CAGR.
GE HealthCare Technologies Inc.'s 3-year revenue CAGR of 3.99% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
GE HealthCare Technologies Inc. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
GE HealthCare Technologies Inc. had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
GE HealthCare Technologies Inc. is overvalued relative to its fair value price of 28.42 based on Discounted Cash Flow model
Undervalued - Earnings yield.
GE HealthCare Technologies Inc. has an earnings yield of 5.02%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
GE HealthCare Technologies Inc. is overvalued relative to its fair value price of 46.04 based on EBITDA multiple model
Undervalued - EV/EBITDA.
GE HealthCare Technologies Inc. has an EV/EBITDA ratio of 11.25x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Overvalued - PEG ratio value.
GE HealthCare Technologies Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
GE HealthCare Technologies Inc. has a price-to-book ratio of 2.81x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
GE HealthCare Technologies Inc. has a price-to-sales ratio of 1.50x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue